Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS) - Kümmerle-Deschner, Jasmin; Ramos, Eduardo; Blank, Norbert; Roesler, Joachim; Felix, Sandra D.; Jung, Thomas; Stricker, Kirstin; Chakraborty, Abhijit; Tannenbaum, Stacey; Wright, Andrew M.; Rordorf, Christiane (Arthritis Research & Therapy, 2011)
Gesehen am 11.07.2022